semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42610271
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.
- 저자
- Jorge Plutzky, Paweł Bogdański, Helen M Colhoun, Selcuk Dagdelen, John E Deanfield, Scott S Emerson
- 저널
- Circulation
- 공개일
- 2026 Aug 18
- 연구 유형
- 기타
- DOI
- 10.1161/CIRCULATIONAHA.125.074482
문헌 요약
In SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), among 17 604 patients with known atherosclerotic cardiovascular disease and overweight or obesity, but not diabetes, randomization to the glucagon-like peptide-1 receptor antagonist semaglutide significantly reduced the primary outcome of major adverse card…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.